Heart Diseases — Study to Evaluate the Optimal Dose of Remifentanil During MRI of the Heart Under General Anaesthesia
Citation(s)
Study to Evaluate the Optimal Dose of Remifentanil Required to Ensure Apnoea During Magnetic Resonance Imaging of the Heart Under General Anaesthesia